Updates on the The Role of Adjuvant Therapy in NSCLC

ESMO 2022 Conference Coverage
T

ESMO 2022 Updated Results From ADAURA: Osimertinib as Adjuvant Therapy in Patients With Resected EGFRm Stage IB–IIIA NSCLC

By ESMO 2022 Conference Coverage FEATURING Tom John
By ESMO 2022 Conference Coverage FEATURING Tom John
652 views
November 8, 2022
Comments 0
Login to view comments. Click here to Login
22:31

Expert Discussion on New Treatment Options for Surgically Resectable…

David Carbone

B. Stiles

281 views
23:32

2023 Updates on Neoadjuvant and Adjuvant NSCLC

2023 West Oncology Conference

M. Johnson

1.4K views
19:23

Evolving Paradigms in the Management of Early-Stage NSCLC

University of Colorado Cancer Center

T. Patil

271 views
19:59

Therapies for Early Stage NSCLC: Adjuvant Chemo/IO

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

J. Spicer

247 views
07:38

Radical Intent NSCLC: Targeted Therapies Update

OncoAlert

S. Popat

444 views
08:01

Multidisciplinary Care in Early Stage NSCLC

UChicago Medicine

J. Donington

368 views
09:17

The Role of Adjuvant Targeted Therapy in rNSCLC

Penn Medicine Abramson Cancer Center

M. Marmarelis

451 views
20:54

The Importance of Mutational Testing in the Adjuvant Setting for NSC…

Peter Illei

307 views
22:51

Approaches to Treatment of Early Stage Lung Cancer When Surgery Won'…

CHEST 2022 Coverage

G. Videtic

355 views
13:51

Adjuvant Treatment of NSCLC: ADAURA in Context

Fox Chase Cancer Center

M. Edelman

551 views
09:45

EGFR Testing in Practices, Treatment Choice, and Clinical Outcomes i…

WCLC 2022 Conference Coverage

J. Subramanian

346 views